Stock Events

Stock Events

Beroni Group Limited 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-644.38%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
358,766.37Revenue
-2.31MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies for infectious diseases, a key area of focus for Beroni as well.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals is involved in biopharmaceutical research, particularly in infectious diseases, competing directly with Beroni's research initiatives.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals focuses on creating new treatments for viral diseases and other chronic conditions, overlapping with Beroni's target markets.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a global biotech leader that develops innovative therapeutics in areas similar to Beroni, including infectious diseases.
Moderna
MRNA
Mkt Cap88.52B
Moderna is known for its mRNA technology used in vaccines, competing in the biotechnological innovation space where Beroni is also active.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech SE works on novel therapies in the biotechnology field, directly competing with Beroni's efforts in biopharmaceuticals.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a large pharmaceutical company with a broad product line that includes treatments for infectious diseases, competing with Beroni's products.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that produces drugs in many of the same categories as Beroni, including viral and other infectious diseases.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca operates in the biopharmaceutical sector focusing on various therapeutic areas, including those targeted by Beroni.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development of pharmaceuticals for infectious diseases, similar to Beroni's focus areas.

About

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.
Show More
CEO
Boqing Zhang
Employees
5
Country
Australia
ISIN
AU000000BTG8
WKN
000A2JA0M

Listings

STU
DE
6B9.STU
MU
DE
6B9.MU
OTC Link
US
BNIGF

0 Comments

Share your thoughts

FAQs

What is Beroni Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Beroni Group Limited stocks are traded under the ticker 6B9.MU.
What is Beroni Group Limited revenue for the last year?▼
Beroni Group Limited revenue for the last year amounts to 358,766.37 EUR.
What is Beroni Group Limited net income for the last year?▼
6B9.MU net income for the last year is -2.31M EUR.
How many employees does Beroni Group Limited have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Beroni Group Limited located?▼
Beroni Group Limited operates in the Health & Wellness sector.
When did Beroni Group Limited complete a stock split?▼
The last stock split for Beroni Group Limited was on October 30, 2023 with a ratio of 1:4.
Where is Beroni Group Limited headquartered?▼
Beroni Group Limited is headquartered in Sydney, Australia.